Not checked for notices yet.

A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status

Alessia Garufi, Silvia Baldari, Riccardo Pettinari and 9 more (opens in a new tab)

Journal of Experimental & Clinical Cancer Research · 2020

doi:10.1186/s13046-020-01628-5 (opens in a new tab)

Cited by papers we hold 1

Mutant p53 in Cancer Progression and Targeted Therapies · 2020
No notice

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.